A recent British study published in European Heart Journal has reignited discussions on the role of sex as a determinant in prescribing anticoagulants, particularly for patients under the age of 65.
DEAR DR. ROACH: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...
Dear Dr. Roach: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I've been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...
BOSTON -- In deciding on anticoagulation with apixaban (Eliquis) for patients with device-detected, subclinical atrial fibrillation (SCAF), one key number appeared to distinguish those for whom the ...
Biomarkers improve CHA2DS2-VASc model fit and predictive ability, with NTproBNP and GDF-15 yielding the best fit. (HealthDay News) — Biomarkers of ischemic stroke risk are positively associated with ...
TCT 1049: Escalating Mortality from Pulmonary Embolism in U.S Women of Reproductive Age: A Retrospective Analysis (1999–2020) with Projections to 2030 Receive the the latest news, research, and ...
A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for predicting stroke among patients with atrial fibrillation (AF) who are taking oral ...
Please provide your email address to receive an email when new articles are posted on . Most patients with a new atrial fibrillation diagnosis do not receive an oral anticoagulant prescription. Odds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results